NCT05809024 2023-04-12Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine TherapyShandong Cancer Hospital and InstitutePhase 4 Recruiting100 enrolled
NCT01660542 2016-11-01An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerYonsei UniversityPhase 4 Completed96 enrolled